Alzheimer’s disaster is no longer ’emerging’ Tomorrow on World Alzheimer’s Time, the Alzheimer’s Association recognizes the attempts of the Obama Administration for getting stakeholders to the table to begin with an important dialogue on how best to address the Alzheimer epidemic. The meeting should come on the heels of the delivery of more than 100,000 petition signatures to people of Congress from Johns and 40 Alzheimer researchers and researchers who tomorrow morning will comprehensive the Alzheimer’s Breakthrough Trip on Capitol Hill click to read more here .D, a co-employee Professor in the Department of Molecular Medicine at the Cleveland Clinic Lerner College of Medication, and the Alzheimer’s Association.

Walter Schmidt adds: It is important to keep in mind that the promising Phase I data with AD02 have already been observed in a relatively small cohort of 24 subjects only. That is a normal number of topics to become treated in stage I studies to demonstrate safety and tolerability; however, this true number is normally too small to attract significant conclusions based on broad statistical significance. We are aware of this situation and we are careful to make sure never to overestimate or over-interpret our positive results. Our actively ongoing phase II study is designed to additional investigate and reproduce the experienced observed positive trends with a cohort of several hundred Alzheimer subjects to meet the respective medical and statistical significance.